This report provides detailed analysis of worldwide markets for Fexofenadine HCl from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Fexofenadine HCl market and further lays out an analysis of the factors influencing the supply/demand for Fexofenadine HCl, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
Fexofenadine HCl (trade names Allegra, Fexidine, Telfast, Fastofen, Tilfur, Vifas, Telfexo, Allerfexo) is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever, nasal congestion, and urticaria. It is often said to be a third-generation antihistamine, which means that its effect are limited to the periphery, that is, outside the brain and spinal cord, which is where most antihistamines mediate their sedating effects, hence fexofenadine produces minimal sedation.
Browse Full Research Report With TOC: http://www.radiantinsights.com/research/global-fexofenadine-hcl-market-outlook-2016-2021
Report has been prepared based on the synthesis, analysis, and interpretation of information about the global Fexofenadine HCl market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Fexofenadine HCl market are Ranbaxy Laboratories Ltd (India), Ind-Swift Laboratories Ltd. (India), Virupaksha Organics Pvt Ltd (India), Tecoland Corp (USA), Jang Su Heng Rui Medine (China), Xi'an Wanlong Pharmaceutical (China), KRRP (China).
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Fexofenadine HCl industry has been provided.
See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/chemicals
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com
Fexofenadine HCl (trade names Allegra, Fexidine, Telfast, Fastofen, Tilfur, Vifas, Telfexo, Allerfexo) is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever, nasal congestion, and urticaria. It is often said to be a third-generation antihistamine, which means that its effect are limited to the periphery, that is, outside the brain and spinal cord, which is where most antihistamines mediate their sedating effects, hence fexofenadine produces minimal sedation.
Browse Full Research Report With TOC: http://www.radiantinsights.com/research/global-fexofenadine-hcl-market-outlook-2016-2021
Report has been prepared based on the synthesis, analysis, and interpretation of information about the global Fexofenadine HCl market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Fexofenadine HCl market are Ranbaxy Laboratories Ltd (India), Ind-Swift Laboratories Ltd. (India), Virupaksha Organics Pvt Ltd (India), Tecoland Corp (USA), Jang Su Heng Rui Medine (China), Xi'an Wanlong Pharmaceutical (China), KRRP (China).
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Fexofenadine HCl industry has been provided.
See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/chemicals
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com
No comments:
Post a Comment